Description bilateral Quchi (LI 11), Hegu (LI 4), Zusanli (ST 36), and Sanyinjiao (SP 6)
Experimental Description
Ninety subjects with T2DM were divided randomly into a control group (n = 30), aerobic exercise group (n = 30), or Acu-TENS group (n = 30). In addition to conventional diabetes drug treatment, patients in the Acu-TENS group received acupoint stimulation, the aerobic exercise group engaged in walking exercises, and the control group was given sham electrical stimulation. All groups were treated for 30 min for each session and five times a week for 2 months.
Sample Count
90
Age
≥55 and ≤75
Control
Sham
Std
control group(n=30);aerobic exercise group(n=30)
Experiment
Acu-TENS group(n=30)
Indicator
HbA1c2h postprandial glucoseFasting serum insulinTriglycerideTotal cholesterolBody mass index(BMI)
Auxiliary Medication
Regular medication for the diabetes
Stimulation Method
TEAS
Induction Method
Electroacupuncture Instrument Model
Manufacturer
Frequency
Waveform
Strength
Induction Time
120Z
WLJ54, Shenzhen, China
10 Hz
discontinuous wave
5 mA
-
Acupuncture_Needle
Needle_Manufacturer
Needle_Depth
-
-
-
Description Four pairs of electrodes were separately fixed at bilateral Quchi (LI 11), Hegu (LI 4), Zusanli (ST 36), and Sanyinjiao (SP 6). TENS (120Z therapeutic apparatus, China) was used, and the stimulation parameters were 10 Hz and 5 mA with a discontinuous wave (muscle contraction 7 times with an interval of 8 seconds between contractions). The stimulation of the acupoints was done with electrode pads (WLJ54, Shenzhen, China). Patients with diabetes received treatment with Acu-TENS by stimulating the selected acupoints.
Clinical Trial Type
randomly
Contraindications
Limbs with metal implants
Effector
The indices of the control group were not changed (P > 0.05) at the three time points. At the pre-treatment measurement, there were significant differences (P > 0.05) in indices among the three groups. At post-treatment, each index of the two groups was lower than that of the control group (P < 0.05), and improved in comparison with the pre-treatment measurement (P < 0.05). In follow-up, each index of the aerobic exercise group and Acu-TENS group increased, but was still decreased compared with the pre-treatment value (P < 0.05), excluding body mass index. Acu-TENS could improve the state of patients with T2DM and be used as a therapy in clinical application.
Effect of transcutaneous electrical nerve stimulation at acupoints on patients with type 2 diabetes mellitus: a randomized controlled trial.
Abstract
OBJECTIVE: To examine whether transcutaneous electric nerve stimulation at acupoints (Acu-TENS) improved the biochemical and physical indices of patients with type 2 diabetes mellitus (T2DM). METHODS: Ninety subjects with T2DM were divided randomly into a control group (n = 30), aerobic exercise group (n = 30), or Acu-TENS group (n = 30). In addition to conventional diabetes drug treatment, patients in the Acu-TENS group received acupoint stimulation, the aerobic exercise group engaged in walking exercises, and the control group was given sham electrical stimulation. All groups were treated for 30 min for each session and five times a week for 2 months. The indices of glycosylated hemoglobin, 2 h postprandial glucose, fasting serum insulin, triglyceride, total cholesterol, and body mass index were assessed at pre-treatment, post-treatment, and follow-up, which was 2 months after treatment. RESULTS: The indices of the control group were not changed (P > 0.05) at the three time points. At the pre-treatment measurement, there were significant differences (P > 0.05) in indices among the three groups. At post-treatment, each index of the two groups was lower than that of the control group (P < 0.05), and improved in comparison with the pre-treatment measurement (P < 0.05). In follow-up, each index of the aerobic exercise group and Acu-TENS group increased, but was still decreased compared with the pre-treatment value (P < 0.05), excluding body mass index. CONCLUSION: Acu-TENS could improve the state of patients with T2DM and be used as a therapy in clinical application."
